Imagen de Portada

Clinical and histopathological parameters in transrectal ultrasound‐guided biopsies associated with tumor upgrading after radical prostatectomy: A comparative analysis of risk groups

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Mustafa Ozkaya, Muhammed Fatih Simsekoglu, Goktug Kalender, Kadir Can Sahin, Iclal Gurses
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Prostate
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Image‐guided multiparametric magnetic resonance imaging‐transrectal ultrasound fusion biopsy augmented with a sextant versus an extended template random biopsy: Comparison of cancer detection rates, complication and functional outcomes
por: Eric S. Adams, et al.
Publicado: (2024)

Nonantibiotic strategies to decrease the postbiopsy hospitalization rates because of infectious complications after transrectal prostate biopsy
por: Coşkun Bostancı
Publicado: (2024)

Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
por: Ghazi Alanazi, et al.
Publicado: (2024)

Overall and metastasis‐free survival of Afro‐Caribbean patients with biochemical recurrence after radical prostatectomy
por: Hugo Barriere, et al.
Publicado: (2024)

Ten‐year functional and oncological outcomes of a prospective randomized controlled trial comparing laparoscopic versus robot‐assisted radical prostatectomy
por: Enrico Checcucci, et al.
Publicado: (2024)

Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
por: Fabian Falkenbach, et al.
Publicado: (2024)

Key learnings from concordant systematic biopsies in prostate‐specific membrane antigen positron emission tomography/computed tomography‐guided prostate biopsies: Enhancing targeting accuracy
por: Thomas Büttner, et al.
Publicado: (2024)

The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health
por: İsa Dağlı, et al.
Publicado: (2025)

Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade‐2 Intermediate‐Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology
por: Serdar Madendere, et al.
Publicado: (2025)

Retrospective analysis of the learning curve in perineal robot‐assisted prostate biopsy
por: Ruth Himmelsbach, et al.
Publicado: (2024)

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
por: Matteo Massanova, et al.
Publicado: (2024)

Retzius‐sparing versus standard robot‐assisted laparoscopic prostatectomy: A two‐year patient‐reported and oncological assessment
por: Romain Diamand, et al.
Publicado: (2024)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
por: Sean A. Fletcher, et al.
Publicado: (2024)

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post‐radiotherapy, and those with de novo metastatic disease
por: Philip Vincent Charlton, et al.
Publicado: (2024)

A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening
por: Jian Gu, et al.
Publicado: (2024)

The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
por: Cevat İlteriş Kıkılı, et al.
Publicado: (2026)

Investigation of pelvic floor influence on prostate displacement in image‐guided radiotherapy
por: Hongbo Chai, et al.
Publicado: (2024)

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
por: Naz Chaudary, et al.
Publicado: (2024)

Prognostic value of circulating tumor cells in oligorecurrent hormone‐sensitive prostate cancer patients undergoing stereotactic body radiation therapy
por: Fabio Matrone, et al.
Publicado: (2024)

Head‐to‐head comparison of GA‐68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer
por: Mustafa Dinckal, et al.
Publicado: (2024)

Differences in real‐world outcomes by risk classification for localized prostate cancer patients after radiation therapy
por: Lawrence Karsh, et al.
Publicado: (2024)

Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS‐plus, 1990–2019: A comparable study of key nations with emerging economies
por: Li‐Sha Luo, et al.
Publicado: (2024)

Is Cystolitholapaxy Sufficient in Patients With Bladder Stones Secondary to Benign Prostatic Obstruction?
por: Mert Hamza Özbilen, et al.
Publicado: (2026)

Predictive Value of PSA Bounce Phenomenon after Stereotactic Body Radiation Therapy in a Large Population of Prostate Cancer Patients Treated By 1.5 T MR Guided Adaptive Technique
por: Andrea Romei, et al.
Publicado: (2025)

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate‐Risk Prostate Cancer Patients With Node‐Negative PSMA PET
por: Baris Esen, et al.
Publicado: (2025)

Predictive factors of infectious complications in patients undergoing prostatectomy
por: Alexandra Cruz Arévalo
Publicado: (2017)

Iodopovidona intrarrectal y riesgo de infección genitourinaria posterior a biopsia prostática transrectal
por: Jorge Moreno-Palacios
Publicado: (2015)

Other‐cause mortality in incidental prostate cancer
por: Francesco Di Bello, et al.
Publicado: (2024)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
por: Takanori Tokunaga, et al.
Publicado: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
por: Yuto Ono, et al.
Publicado: (2025)

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
por: Hyun‐Kyung Ko, et al.
Publicado: (2025)

Cover Image: Volume 86 Issue 7
por: Amod Sharma, et al.
Publicado: (2026)

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high‐grade prostate cancer patients
por: Nawar Touma, et al.
Publicado: (2024)

Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
por: Eric V. Li, et al.
Publicado: (2024)

Discovering the Prostate: Notes on History and Historiography
por: Diederik F. Janssen
Publicado: (2025)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
por: Toshifumi Takahashi, et al.
Publicado: (2024)

USPSTF Recommendation Against PSA Screening vs. Stage and Cancer‐Specific Mortality in Localized Prostate Cancer
por: Fabian Falkenbach, et al.
Publicado: (2025)

Insights and Limitations in Evaluating Testosterone Recovery With LHRH Antagonists and Agonists
por: Satı Coşkun Yazgan, et al.
Publicado: (2026)

Real‐World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: A Propensity‐Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis
por: Yosuke Yasuda, et al.
Publicado: (2026)

Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
por: Mark Kidd, et al.
Publicado: (2025)